vs
Side-by-side financial comparison of IHS Holding Ltd (IHS) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
IHS Holding Ltd is the larger business by last-quarter revenue ($254.0M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). On growth, IHS Holding Ltd posted the faster year-over-year revenue change (0.1% vs -22.7%). IHS Holding Ltd produced more free cash flow last quarter ($178.6M vs $-36.6M). Over the past eight quarters, PTC THERAPEUTICS, INC.'s revenue compounded faster (-11.5% CAGR vs -22.0%).
IHS Towers is one of the largest independent owners, operators and developers of shared communications infrastructure in the world, with operations across Africa and Latin America. It is the fifth-largest independent multinational tower company in the world.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
IHS vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $254.0M | $164.7M |
| Net Profit | — | $-135.0M |
| Gross Margin | 83.6% | — |
| Operating Margin | — | -43.3% |
| Net Margin | — | -82.0% |
| Revenue YoY | 0.1% | -22.7% |
| Net Profit YoY | — | -104.8% |
| EPS (diluted) | — | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $254.0M | $164.7M | ||
| Q3 25 | $455.1M | $211.0M | ||
| Q2 25 | $433.3M | $178.9M | ||
| Q1 25 | $439.6M | $1.2B | ||
| Q4 24 | $253.8M | $213.2M | ||
| Q3 24 | $420.3M | $196.8M | ||
| Q2 24 | $435.4M | $186.7M | ||
| Q1 24 | $417.7M | $210.1M |
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $147.4M | $15.9M | ||
| Q2 25 | $32.3M | $-64.8M | ||
| Q1 25 | $30.7M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $-205.7M | $-106.7M | ||
| Q2 24 | $-124.3M | $-99.2M | ||
| Q1 24 | $-1.6B | $-91.6M |
| Q4 25 | 83.6% | — | ||
| Q3 25 | 47.5% | — | ||
| Q2 25 | 51.3% | — | ||
| Q1 25 | 51.4% | — | ||
| Q4 24 | 72.1% | — | ||
| Q3 24 | 52.0% | — | ||
| Q2 24 | 52.5% | — | ||
| Q1 24 | 39.1% | — |
| Q4 25 | — | -43.3% | ||
| Q3 25 | 35.1% | 1.4% | ||
| Q2 25 | 33.8% | -19.5% | ||
| Q1 25 | 37.1% | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | 29.9% | -27.7% | ||
| Q2 24 | 34.0% | -21.5% | ||
| Q1 24 | -1.7% | -21.6% |
| Q4 25 | — | -82.0% | ||
| Q3 25 | 32.4% | 7.5% | ||
| Q2 25 | 7.5% | -36.3% | ||
| Q1 25 | 7.0% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | -48.9% | -54.2% | ||
| Q2 24 | -28.5% | -53.1% | ||
| Q1 24 | -372.8% | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $0.44 | $0.20 | ||
| Q2 25 | $0.10 | $-0.83 | ||
| Q1 25 | $0.10 | $10.04 | ||
| Q4 24 | — | $-0.85 | ||
| Q3 24 | $-0.61 | $-1.39 | ||
| Q2 24 | $-0.36 | $-1.29 | ||
| Q1 24 | $-4.67 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $825.7M | $1.9B |
| Total DebtLower is stronger | $3.1B | — |
| Stockholders' EquityBook value | $-89.8M | $-205.3M |
| Total Assets | $4.5B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $825.7M | $1.9B | ||
| Q3 25 | $647.6M | $1.7B | ||
| Q2 25 | $531.8M | $2.0B | ||
| Q1 25 | $629.0M | $2.0B | ||
| Q4 24 | $578.0M | $1.1B | ||
| Q3 24 | $397.5M | $1.0B | ||
| Q2 24 | $445.7M | $1.1B | ||
| Q1 24 | $333.2M | $884.8M |
| Q4 25 | $3.1B | — | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.4B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.5B | — |
| Q4 25 | $-89.8M | $-205.3M | ||
| Q3 25 | $38.1M | $-155.8M | ||
| Q2 25 | $-98.4M | $-206.5M | ||
| Q1 25 | $-184.4M | $-185.8M | ||
| Q4 24 | $-314.4M | $-1.1B | ||
| Q3 24 | $-284.7M | $-1.1B | ||
| Q2 24 | $-308.3M | $-980.2M | ||
| Q1 24 | $-163.2M | $-893.9M |
| Q4 25 | $4.5B | $2.9B | ||
| Q3 25 | $4.7B | $2.6B | ||
| Q2 25 | $4.5B | $2.6B | ||
| Q1 25 | $4.4B | $2.7B | ||
| Q4 24 | $4.2B | $1.7B | ||
| Q3 24 | $4.6B | $1.8B | ||
| Q2 24 | $4.5B | $1.9B | ||
| Q1 24 | $4.6B | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | 85.85× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $246.9M | $-34.3M |
| Free Cash FlowOCF − Capex | $178.6M | $-36.6M |
| FCF MarginFCF / Revenue | 70.3% | -22.3% |
| Capex IntensityCapex / Revenue | 26.9% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $718.7M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $246.9M | $-34.3M | ||
| Q3 25 | $251.3M | $-66.3M | ||
| Q2 25 | $237.7M | $-58.3M | ||
| Q1 25 | $200.3M | $870.1M | ||
| Q4 24 | $344.4M | $-30.0M | ||
| Q3 24 | $174.5M | $-77.0M | ||
| Q2 24 | $134.7M | $-71.5M | ||
| Q1 24 | $75.8M | $70.8M |
| Q4 25 | $178.6M | $-36.6M | ||
| Q3 25 | $189.2M | $-69.7M | ||
| Q2 25 | $197.7M | $-59.6M | ||
| Q1 25 | $153.2M | $868.4M | ||
| Q4 24 | $282.9M | $-33.8M | ||
| Q3 24 | $122.3M | $-77.5M | ||
| Q2 24 | $74.2M | $-78.8M | ||
| Q1 24 | $14.8M | $61.2M |
| Q4 25 | 70.3% | -22.3% | ||
| Q3 25 | 41.6% | -33.1% | ||
| Q2 25 | 45.6% | -33.3% | ||
| Q1 25 | 34.8% | 73.8% | ||
| Q4 24 | 111.5% | -15.8% | ||
| Q3 24 | 29.1% | -39.4% | ||
| Q2 24 | 17.0% | -42.2% | ||
| Q1 24 | 3.5% | 29.1% |
| Q4 25 | 26.9% | 1.4% | ||
| Q3 25 | 13.6% | 1.6% | ||
| Q2 25 | 9.2% | 0.7% | ||
| Q1 25 | 10.7% | 0.1% | ||
| Q4 24 | 24.2% | 1.8% | ||
| Q3 24 | 12.4% | 0.3% | ||
| Q2 24 | 13.9% | 4.0% | ||
| Q1 24 | 14.6% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 1.70× | -4.17× | ||
| Q2 25 | 7.36× | — | ||
| Q1 25 | 6.52× | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
